The 13thth World Stem Cell Summit www.worldstemcellsummit.com is taking place January 23-26, 2018 at the Hyatt Regency Miami. Produced by the nonprofit Regenerative Medicine Foundation (RMF), the event is the global ecosystem meeting for advanced therapies; fostering public understanding, promoting positive policy initiatives and collaborations.
|
|||
The World Stem Cell Summit will be co-located with the field’s premier industry partnering event, Phacilitate Leaders Forum, Cell & Gene Therapy World and Immunotherapy World.
In addition to compelling keynotes, plenary and focus sessions, the diverse four-day program includes expert lunch roundtables; a centrally located Expo packed with innovators in industry, academia and government; a poster forum showcasing science and policy research; the gala Stem Cell Action Awards Dinner http://regmedfoundation.org/awards/; as well as many exclusive networking and partnering opportunities.
RMF Executive Director Bernard Siegel, founder and co-chair of the Summit said, “We are proud to select Miami to be our host for the next World Stem Cell Summit. Miami is often referred to as the 'City of the Future' and in 2018 it will be the center of the stem cell universe. It’s the perfect venue for Summit attendees to gain knowledge, network and collect opportunities to advance their goals, in a superlative, cosmopolitan setting.”
ABOUT RMF Regenerative Medicine Foundation is dedicated to accelerating regenerative medicine to improve health and deliver cures. RMF pursues its mission by producing its flagship World Stem Cell Summit, honoring leaders through the Stem Cell Action Awards http://worldstemcellsummit.com/stem-cell-action-awards/, publishing the World Stem Cell Report and RegMed Newsletter, organizing educational initiatives such as the upcoming Regenerative Medicine Essentials Course http://www.wakehealth.edu/Research/WFIRM/RMEssentials/Regenerative-Medicine-Essentials.htm and fostering strategic collaborations.
For more information about RMF, visit www.regmedfoundation.org or contact Bernard Siegel directly at [email protected].
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/64ef8cd8-84a3-4130-8a8f-f1e020eaeba3
Bernard Siegel Regenerative Medicine Foundation 3058014928 [email protected]


RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
Bank of America's $72.5M Epstein Settlement: What You Need to Know
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand 



